Merck KGaA
Diatech Pharmacogenetics, Merck KGaA Expand RAS Biomarker Testing Pact in Middle East, Africa
The companies are collaborating to improve access to biomarker testing to inform the use of targeted therapies in colorectal cancer across the region.
MilliporeSigma, Opentrons Labworks Partner for Automated Assay Solutions
The companies will team up to develop and validate automated workflows using assays from MilliporeSigma and the custom Flex workstation from Opentrons.
Foundation Medicine Companion Dx Test Gets FDA OK for Use with Merck's Tepmetko in Lung Cancer
The blood-based comprehensive genomic profiling test uses next-generation sequencing to analyze 324 genes.
Biocartis, Merck KGaA Extend RAS Testing Partnership to Middle East, North Africa
The companies hope to improve access to biomarker testing to direct more personalized treatment for cancer patients in the region.
Caris Life Sciences, Merck KGaA Strike Cancer Drug Discovery Partnership
The deal could be worth as much as $1.4 billion to Caris, which will discover and validate targets for Merck to develop into new antibody-drug conjugates.
Aug 3, 2020
Metabolon, Merck KGaA Form Metabolomics Alliance
Jun 20, 2018
Dec 27, 2017